What is Myriad Genetics's free cash flow?

Myriad Genetics (MYGN) reported free cash flow of -$19.7M in Q2 2023.

How has Myriad Genetics's free cash flow changed year-over-year?

Myriad Genetics's free cash flow increased by 65.1% year-over-year, from -$56.4M to -$19.7M.

What does free cash flow mean?

Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Myriad Genetics MYGN Free cash flow

Discontinued — last reported Q2 '23

Free cash flow at other companies

NeoGenomicsNEO

-$13.14M+56.0%

VeracyteVCYT

$32.25M+810%

Natera, Inc.NTRA

$18.03M-20.3%

Labcorp HoldingsLH

——

Quest DiagnosticsDGX

——

Guardant HealthGH

——

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

−$900.0Knet cash from operating−$18.8Mcapital expenditures=-$19.7M

The official record: Myriad Genetics’s 10-Q, filed August 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's free cash flow?: Myriad Genetics (MYGN) reported free cash flow of -$19.7M in Q2 2023.
How has Myriad Genetics's free cash flow changed year-over-year?: Myriad Genetics's free cash flow increased by 65.1% year-over-year, from -$56.4M to -$19.7M.
What does free cash flow mean?: Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.